Fed. Cir.

Shire LLC v. amneal Pharmaceuticals, LLC, No. 14-1736 (Fed. Cir. Sept. 24, 2015)

Errata

Court: U.S. Court of Appeals for the Federal Circuit
Case No.: No. 14-1736
Decided: September 24, 2015
Judge: —
Document: Errata
Length: 2 pages

Full Text Analysis Cite this Opinion

Download Opinion (PDF)

United States Court of Appeals

for the Federal Circuit

October 9, 2015

ERRATA

Appeal Nos. 2014-1736, -1737, -1738, -1739, -1740, -1741 SHIRE LLC, SHIRE DEVELOPMENT INC., SHIRE

DEVELOPMENT, LLC,

Plaintiffs-Appellees

AMNEAL PHARMACEUTICALS, LLC, ROXANE

LABORATORIES INC., SANDOZ INC., MYLAN INC.,

MYLAN PHARMACEUTICALS INC., JOHNSON

MATTHEY INC., JOHNSON MATTHEY

PHARMACEUTICAL MATERIALS, ACTAVIS

ELIZABETH LLC, ACTAVIS LLC,

Defendants-Appellants

Decided: September 24, 2015

Precedential Opinion

Please make the following change: On page two, replace the sentence

22 PAPST LICENSING V. FUJIFILM CORPORATION

DANIEL E. YONAN, Blank Rome LLP, Washington, DC, for defendant-appellant Amneal Pharmaceuticals, LLC. with the following sentence: DANIEL E. YONAN, Sterne Kessler Goldstein & Fox, PLLC, Washington, DC, for defendant-appellant Amneal Pharmaceuticals, LLC.

Text extracted from the official PDF and reflowed for reading. It is not a certified transcript — the PDF linked above is the authoritative document.

Analysis is coming soon.

A plain-English account of the issues, facts and holding, written by Patent Case Watch. The opinion itself — its full text, its PDF and everything else on this page — stays free to read for everyone, always.

Cite this opinion

Shire LLC v. amneal Pharmaceuticals, LLC, No. 14-1736 (Fed. Cir. Sept. 24, 2015).

govinfo ID: USCOURTS-ca13-14-01736-1
Permalink: https://patentcasewatch.com/opinions/USCOURTS-ca13-14-01736-1

No reporter citation is shown because the official source does not supply one; none is inferred here. Check the opinion and a citator before relying on this form.

Source: govinfo.gov USCOURTS collection · retrieved July 25, 2026 · Report an error